133 related articles for article (PubMed ID: 37259798)
1. Pancreatic Cancer Disparities among Gender, Race, and Ethnicity: The PRECEDE Consortium Outcomes and Impact.
Yamada HY; Rao CV
Cancer Prev Res (Phila); 2023 Jun; 16(6):305-307. PubMed ID: 37259798
[TBL] [Abstract][Full Text] [Related]
2. Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance.
Katona BW; Klute K; Brand RE; Everett JN; Farrell JJ; Hawthorne K; Kaul V; Kupfer SS; Paiella S; Simeone DM; Sussman DA; Zogopoulos G; Lucas AL; Kastrinos F;
Cancer Prev Res (Phila); 2023 Jun; 16(6):343-352. PubMed ID: 37259800
[TBL] [Abstract][Full Text] [Related]
3. The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals.
Zogopoulos G; Haimi I; Sanoba SA; Everett JN; Wang Y; Katona BW; Farrell JJ; Grossberg AJ; Paiella S; Klute KA; Bi Y; Wallace MB; Kwon RS; Stoffel EM; Wadlow RC; Sussman DA; Merchant NB; Permuth JB; Golan T; Raitses-Gurevich M; Lowy AM; Liau J; Jeter JM; Lindberg JM; Chung DC; Earl J; Brentnall TA; Schrader KA; Kaul V; Huang C; Chandarana H; Smerdon C; Graff JJ; Kastrinos F; Kupfer SS; Lucas AL; Sears RC; Brand RE; Parmigiani G; Simeone DM;
J Natl Compr Canc Netw; 2024 Apr; 22(3):158-166. PubMed ID: 38626807
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) Consortium.
Gonda TA; Everett JN; Wallace M; Simeone DM;
Gastroenterology; 2021 Dec; 161(6):1751-1757. PubMed ID: 34454916
[No Abstract] [Full Text] [Related]
5. Standardization of MRI Screening and Reporting in Individuals With Elevated Risk of Pancreatic Ductal Adenocarcinoma: Consensus Statement of the PRECEDE Consortium.
Huang C; Simeone DM; Luk L; Hecht EM; Khatri G; Kambadakone A; Chandarana H; Ream JM; Everett JN; Guimaraes A; Liau J; Dasyam AK; Harmath C; Megibow AJ;
AJR Am J Roentgenol; 2022 Dec; 219(6):903-914. PubMed ID: 35856454
[TBL] [Abstract][Full Text] [Related]
6. Associations of gender, race, and ethnicity with disparities in short-term adverse outcomes after pancreatic resection for cancer.
Pastrana Del Valle J; Mahvi DA; Fairweather M; Wang J; Clancy TE; Ashley SW; Urman RD; Whang EE; Gold JS
J Surg Oncol; 2022 Mar; 125(4):646-657. PubMed ID: 34786728
[TBL] [Abstract][Full Text] [Related]
7. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
8. Results of First-Round of Surveillance in Individuals at High-Risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry.
Paiella S; Capurso G; Cavestro GM; Butturini G; Pezzilli R; Salvia R; Signoretti M; Crippa S; Carrara S; Frigerio I; Bassi C; Falconi M; Iannicelli E; Giardino A; Mannucci A; Laghi A; Laghi L; Frulloni L; Zerbi A
Am J Gastroenterol; 2019 Apr; 114(4):665-670. PubMed ID: 30538291
[TBL] [Abstract][Full Text] [Related]
9. Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.
Canto MI; Hruban RH; Fishman EK; Kamel IR; Schulick R; Zhang Z; Topazian M; Takahashi N; Fletcher J; Petersen G; Klein AP; Axilbund J; Griffin C; Syngal S; Saltzman JR; Mortele KJ; Lee J; Tamm E; Vikram R; Bhosale P; Margolis D; Farrell J; Goggins M;
Gastroenterology; 2012 Apr; 142(4):796-804; quiz e14-5. PubMed ID: 22245846
[TBL] [Abstract][Full Text] [Related]
10. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
Goggins M; Overbeek KA; Brand R; Syngal S; Del Chiaro M; Bartsch DK; Bassi C; Carrato A; Farrell J; Fishman EK; Fockens P; Gress TM; van Hooft JE; Hruban RH; Kastrinos F; Klein A; Lennon AM; Lucas A; Park W; Rustgi A; Simeone D; Stoffel E; Vasen HFA; Cahen DL; Canto MI; Bruno M;
Gut; 2020 Jan; 69(1):7-17. PubMed ID: 31672839
[TBL] [Abstract][Full Text] [Related]
11. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements.
Dbouk M; Brewer Gutierrez OI; Lennon AM; Chuidian M; Shin EJ; Kamel IR; Fishman EK; He J; Burkhart RA; Wolfgang CL; Hruban RH; Goggins MG; Canto MI
Pancreatology; 2021 Apr; 21(3):613-621. PubMed ID: 33593706
[TBL] [Abstract][Full Text] [Related]
12. Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results.
Paiella S; Salvia R; De Pastena M; Pollini T; Casetti L; Landoni L; Esposito A; Marchegiani G; Malleo G; De Marchi G; Scarpa A; D'Onofrio M; De Robertis R; Pan TL; Maggino L; Andrianello S; Secchettin E; Bonamini D; Melisi D; Tuveri M; Bassi C
Pancreatology; 2018 Jun; 18(4):420-428. PubMed ID: 29709409
[TBL] [Abstract][Full Text] [Related]
13. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis.
Chhoda A; Vodusek Z; Wattamwar K; Mukherjee E; Gunderson C; Grimshaw A; Sharma A; Ahuja N; Kastrinos F; Farrell JJ
Gastroenterology; 2022 Mar; 162(3):786-798. PubMed ID: 34813861
[TBL] [Abstract][Full Text] [Related]
14. The emotional impact of surveillance programs for pancreatic cancer on high-risk individuals: A prospective analysis.
Paiella S; Marinelli V; Secchettin E; Mazzi MA; Ferretto F; Casolino R; Bassi C; Salvia R
Psychooncology; 2020 Jun; 29(6):1004-1011. PubMed ID: 32108397
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in
Saldia A; Olson SH; Nunes P; Liang X; Samson ML; Salo-Mullen E; Marcell V; Stadler ZK; Allen PJ; Offit K; Kurtz RC
Cancer Prev Res (Phila); 2019 Sep; 12(9):599-608. PubMed ID: 31337648
[TBL] [Abstract][Full Text] [Related]
16. Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?
Wang Y; Cuggia A; Chen YI; Parent J; Stanek A; Denroche RE; Zhang A; Grant RC; Domecq C; Golesworthy B; Shwaartz C; Borgida A; Holter S; Wilson JM; Chong G; O'Kane GM; Knox JJ; Fischer SE; Gallinger S; Gao ZH; Foulkes WD; Waschke KA; Zogopoulos G
J Natl Compr Canc Netw; 2022 Jun; 20(6):663-673.e12. PubMed ID: 35714671
[TBL] [Abstract][Full Text] [Related]
17. Surveillance for neoplasia in the pancreas.
Overbeek KA; Cahen DL; Canto MI; Bruno MJ
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):971-986. PubMed ID: 27938791
[TBL] [Abstract][Full Text] [Related]
18. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention.
Stoffel EM; Brand RE; Goggins M
Gastroenterology; 2023 Apr; 164(5):752-765. PubMed ID: 36804602
[TBL] [Abstract][Full Text] [Related]
20. Disparities in Access to Oncologic Care in Pancreatic Cancer: A Systematic Review.
Fonseca AL; Khan H; Mehari KR; Cherla D; Heslin MJ; Johnston FM
Ann Surg Oncol; 2022 May; 29(5):3232-3250. PubMed ID: 35067789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
